Bilirubin Prevents the TH⁺ Dopaminergic Neuron Loss in a Parkinson's Disease Model by Acting on TNF-α.

ABSTRACT: Parkinson's disease (PD), the fastest-growing movement disorder, is still challenged by the unavailability of disease-modifying therapy. Mildly elevated levels of unconjugated bilirubin (UCB, PubChem CID 5280352) have been shown to be protective against several extra-CNS diseases, and the effect is attributed to its well-known anti-oxidant and anti-inflammatory capability. We explored the neuroprotective effect of low concentrations of UCB (from 0.5 to 4 µM) in our PD model based on organotypic brain cultures of substantia nigra (OBCs-SN) challenged with a low dose of rotenone (Rot). UCB at 0.5 and 1 µM fully protects against the loss of TH⁺ (dopaminergic) neurons (DOPAn). The alteration in oxidative stress is involved in TH⁺ positive neuron demise induced by Rot, but

SUBMITTER: Jayanti S 

PROVIDER: S-EPMC9693357 | biostudies-literature | 2022 Nov

REPOSITORIES: biostudies-literature